Stanford researchers have uncovered a potential role for a protein called TREM1 in the development of age-related inflammation, cognitive decline, and Alzheimer's disease. This discovery could pave the way for new therapeutic ...
Mar 28, 2024
0
30
A novel treatment for leukemias and lymphomas that arise from immune system T cells, developed by investigators at the Johns Hopkins Kimmel Cancer Center and its Ludwig Center and Lustgarten Laboratory, was found to be effective ...
Apr 2, 2024
0
26
You're not in your 20s or 30s anymore and you know regular health checks are important. So you go to your GP. During the appointment they measure your waist. They might also check your weight. Looking concerned, they recommend ...
Apr 19, 2024
0
0
Microglia are specialized immune cells in the brain. While they normally protect our brains, they can also contribute to neurodegenerative diseases such as Alzheimer's. The exact mechanism behind this contribution is not ...
Mar 27, 2024
0
47
People who use e-cigarettes are significantly more likely to develop heart failure compared with those who have never used them, according to one of the largest prospective studies to date investigating possible links between ...
Apr 2, 2024
0
5
Researchers have been chipping away at the genetic causes of congenital heart disease (CHD) for a couple of decades. About 45% of cases of CHD have an identifiable cause, including chromosomal abnormalities, genetic variants ...
Apr 8, 2024
0
12
A novel, injectable shear-thinning hydrogel for treating abdominal aortic aneurysms (AAA) has been developed by scientists at the Terasaki Institute for Biomedical Innovation (TIBI). This hydrogel not only demonstrates increased ...
Mar 26, 2024
0
0
A large multi-state electronic health record-based study from the Centers for Disease Control and Prevention's (CDC's) VISION Network has found that COVID-19 vaccines are as effective for adults with anxiety, depression, ...
Apr 3, 2024
0
4
Alzheimer's disease (AD) currently afflicts nearly seven million people in the U.S. With this number expected to grow to nearly 13 million by 2050, the lack of meaningful therapies represents a major unmet medical need. Scientists ...
Apr 16, 2024
0
0
University of Hawaiʻi Cancer Center researchers have conducted a phase II clinical trial investigating the potential of pembrolizumab maintenance therapy, a type of immunotherapy, in aggressive forms of breast cancer. The ...
Apr 18, 2024
0
9
